Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iSpecimen (ISPC) Return on Sales (2020 - 2025)

iSpecimen has reported Return on Sales over the past 6 years, most recently at 51.92% for Q4 2025.

  • Quarterly results put Return on Sales at 51.92% for Q4 2025, down 4786.0% from a year ago — trailing twelve months through Dec 2025 was 4.65% (down 327.0% YoY), and the annual figure for FY2025 was 4.65%, down 327.0%.
  • Return on Sales for Q4 2025 was 51.92% at iSpecimen, down from 26.55% in the prior quarter.
  • Over the last five years, Return on Sales for ISPC hit a ceiling of 0.01% in Q4 2021 and a floor of 51.92% in Q4 2025.
  • Median Return on Sales over the past 5 years was 1.02% (2022), compared with a mean of 4.99%.
  • Biggest five-year swings in Return on Sales: skyrocketed 137bps in 2024 and later plummeted -4786bps in 2025.
  • iSpecimen's Return on Sales stood at 0.01% in 2021, then tumbled by -6187bps to 0.73% in 2022, then tumbled by -51bps to 1.1% in 2023, then crashed by -270bps to 4.06% in 2024, then crashed by -1178bps to 51.92% in 2025.
  • The last three reported values for Return on Sales were 51.92% (Q4 2025), 26.55% (Q3 2025), and 2.55% (Q2 2025) per Business Quant data.